AMST Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: February 09, 2026
Report Source: 2026 2nd Quarter Report
Amesite Inc. Stock Analysis AMST
Amesite, Inc. is a technology company, which engages in the development and marketing of B2C and B2B AI-driven solutions for the healthcare sector. The company is headquartered in Ann Arbor, Michigan and currently employs 6 full-time employees. The company went IPO on 2020-09-25. The firm focused on building and commercializing AI-powered solutions for the healthcare sector. The firm specializes in the development and marketing of business-to-consumer (B2C) and business-to-business (B2B) artificial intelligence (AI)-driven solutions, including its higher ed platform that offers professional learning. The firm's platform utilizes infrastructure to deliver both Amesite Engage for higher education and NurseMagic for healthcare. NurseMagic is a mobile app for healthcare professionals, streamlines creation of nursing notes and documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace situations. NurseMagic is designed for use across various healthcare modalities, such as skilled nursing, assisted living, memory care, home health, and rehabilitation centers.
Read More Amesite Inc (AMST) Chart
Key Statistics of Amesite Inc (AMST)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.83Volume
43.34KP/E Ratio (TTM)
-52 Week Range
Market Cap
5.16MAvg. Volume
737.46KDividend Yield
-Financial Metrics & Statements of Amesite Inc (AMST)
FAQ's for Amesite Inc (AMST)
- According to Musaffa’s Shariah screening methodology, Amesite Inc (AMST) is currently classified as NOT HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.